Erschienen in:
16.02.2023 | COMMENTARY
Catheter ablation as first-line therapy for ventricular tachycardia: is it time for a paradigm shift?
verfasst von:
Maiwand Mirwais, Timothy M. Markman
Erschienen in:
Journal of Interventional Cardiac Electrophysiology
|
Ausgabe 7/2023
Einloggen, um Zugang zu erhalten
Excerpt
Ventricular tachycardia (VT) is the electrophysiological manifestation of abnormal myocardial remodeling in the setting of complex ischemic, non-ischemic, or mixed substrates. Despite the fact that a majority of large referral centers have reported encouraging outcomes in patients undergoing catheter ablation (CA) for VT, prospective evaluations have been lacking due to the complexities of ventricular arrhythmias and diversity of the population being studied. Specifically, there has been uncertainty surrounding the role of early CA for patients with a first presentation of VT. For these patients, it is unclear whether CA prior to implantable cardioverter defibrillator (ICD) placement is more effective than a more traditional therapy of ICD placement and antiarrhythmic medications. …